Chargement en cours...
A clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyond
The prevalence of type 2 diabetes is increasing at an astounding rate. Many of the agents used to treat type 2 diabetes have undesirable adverse effects of hypoglycemia and weight gain. Glucagon-like peptide-1 (GLP-1) receptor agonists represent a unique approach to the treatment of diabetes, with b...
Enregistré dans:
| Publié dans: | Drugs Context |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Just Medical Media Limited
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4509428/ https://ncbi.nlm.nih.gov/pubmed/26213556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212283 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|